Hims vs Hers Canada (2026): Which GLP-1 Program Is Right for You?

When a company builds two consumer health brands aimed at different genders, the cynical reading is that it's the same product with different colour palettes. The reality with Hims and Hers in Canada is more nuanced. Both platforms emerged from Hims & Hers Health, a US company that has scaled to millions of subscribers by breaking down the friction between consumer health concerns and prescriptions. Both launched Canadian operations through the same parent infrastructure - shared payment systems, shared partner pharmacy network, shared async intake architecture.

But the clinical content between them is meaningfully different, and those differences are most pronounced in the weight management category. GLP-1 medications interact with hormonal systems in ways that create distinct considerations for men and women. Insulin sensitivity, body composition response, and the interplay between weight loss and reproductive hormones all differ by sex in ways that a well-designed clinical intake should capture. This comparison examines whether Hims and Hers actually deliver on the promise of gender-specific care, or whether the differentiation is primarily cosmetic.

Platform Overview

Shared Infrastructure

Understanding what Hims and Hers share is essential context for understanding where they genuinely differ. The two brands operate on the same technology platform. The intake questionnaire system, the physician review workflow, the partner pharmacy dispatch network, and the subscription billing infrastructure are all common to both. When you complete an intake on either brand, the underlying process - a digital form reviewed asynchronously by a licensed Canadian physician who communicates back with a prescribing decision - is structurally identical.

Province availability is also shared. Both brands currently exclude Quebec and New Brunswick in Canada, reflecting the same operational constraints around the parent company's Canadian physician licensing and pharmacy partnership footprint. If you can access one, you can access the other.

Pricing transparency operates the same way on both: the program cost is disclosed after you have completed the health questionnaire rather than before you begin. That is a deliberate intake-funnel design that reflects the US direct-to-consumer health model the parent company perfected. Canadian patients who want to compare costs before committing time to a questionnaire will encounter the same friction on either brand.

Gender-Specific Clinical Focus

The substantive differences between Hims and Hers live in the clinical content that each platform's intake has been designed to capture. This is not cosmetic differentiation - the questions a physician needs answered before prescribing a GLP-1 to a woman are genuinely different from those most relevant for a man.

Hers Canada's GLP-1 intake questionnaire incorporates menstrual cycle history, PCOS diagnosis, current contraceptive use, hormonal medication, and reproductive health context. These factors are clinically relevant because GLP-1 medications affect insulin signalling and can interact with hormonal systems in ways that are specifically important for women - particularly those with PCOS, for whom semaglutide has well-documented benefits beyond weight loss. The Hers clinical team is accustomed to evaluating weight management in the context of these factors.

Hims Canada's GLP-1 intake is calibrated for male metabolic health context. The questions relevant to men - cardiovascular risk factors, testosterone levels, sleep apnea, erectile function - are more prominently featured. Men with metabolic syndrome patterns that include central adiposity, insulin resistance, and hypogonadism represent a significant proportion of the male GLP-1 population, and a clinical intake built for men captures those patterns differently than a gender-neutral form would.

In both cases, the intake design matters most at the beginning of treatment, when prescribing eligibility and starting dose are being established. The ongoing clinical interaction for both platforms is limited - neither Hims nor Hers offers on-demand physician access, so the quality of the initial intake has an outsized effect on treatment outcomes compared to platforms where real-time clinical adjustment is readily available.

Pricing Comparison

Because both platforms are operated by the same parent company using the same pharmacy network, GLP-1 program pricing between Hims and Hers Canada tends to be broadly comparable. The specific figures vary by dose tier and program configuration, but neither brand appears to price its GLP-1 program at a meaningful premium or discount relative to the other.

Province Coverage

Province coverage is identical between the two brands - both reflect the same Canadian operational footprint of their parent company. Eight provinces are served; Quebec and New Brunswick are excluded. Patients in those two provinces should look at Maple, DirectMeds, or MyRocky, all of which have broader provincial coverage.

Health Ecosystems

The value proposition of Hims and Hers extends beyond GLP-1 for patients who have adjacent health concerns that fall within each brand's category focus. Whether that ecosystem value is relevant to you depends entirely on your individual health needs.

Hims Canada's ecosystem is built around men's lifestyle health. A male patient managing weight loss alongside hair thinning - common in men with elevated DHT levels, which can be affected by metabolic changes during GLP-1 treatment - can address both through the same subscription relationship. Erectile dysfunction treatments, which are often sought by men in the same demographic as GLP-1 patients, are available through the same platform. Skincare for men who want to address the skin changes that accompany significant weight loss rounds out the portfolio.

Hers Canada's ecosystem centres on women's health categories that frequently co-occur with or are affected by weight management. Hormonal contraception - particularly relevant given that rapid weight loss can affect the efficacy of some oral contraceptives - is available on the platform. Women's hair loss, which can be triggered or worsened by the caloric restriction and nutrient flux associated with GLP-1 treatment, is another category that Hers handles within the same clinical environment. Those co-occurrences are not coincidental: Hers has structured its offerings around the health concerns that most commonly cluster together for women in the GLP-1 age bracket.

Clinical Oversight Quality

On the narrow question of GLP-1 clinical oversight quality, Hims and Hers are comparable. Both use the same underlying intake infrastructure, both engage licensed Canadian physicians for prescribing decisions, and both rely on asynchronous communication for ongoing clinical contact. Neither platform offers on-demand physician access as part of its standard GLP-1 program.

The limitations of that model apply equally to both brands. Patients who encounter side effects outside business hours must wait for an async response rather than speaking immediately with a physician. Dose adjustment decisions are slower than on a platform with real-time physician access. Complex clinical questions - drug interactions with newly added medications, for example - require sending a message and waiting rather than picking up a phone.

For patients who want real-time physician access as part of their GLP-1 program, Maple is a better choice than either Hims or Hers. For patients who are comfortable with async clinical contact and prioritise the gender-specific program framing and dispensing convenience of the Hims and Hers model, the clinical oversight quality of either brand is adequate for straightforward cases.

Switching Between Brands

Because Hims and Hers share infrastructure, there is a common question about whether a patient who started on one brand can transfer to the other. In practice, this scenario most commonly arises for non-binary individuals, for people who enrolled on the wrong brand by mistake, or for people whose gender-specific health needs have changed.

The brands do not advertise a formal transfer process, but both require a new intake for prescribing. A patient who wants to access women's health categories through Hers after starting GLP-1 treatment through Hims would need to complete a new Hers intake. Whether that results in a new prescription being issued or simply in access to the additional health categories depends on the clinical review. The two brands' clinical records are not automatically shared, so a complete new clinical history is typically required.

For most patients, this is a minor logistical step rather than a significant barrier. For patients who want to avoid the cost of a second intake, it is worth choosing the right brand for your demographics and health needs before completing the first one.

Pros and Cons

Verdict

Between Hims and Hers Canada, the deciding factor is your gender and whether the associated health ecosystem adds value for you. This is genuinely a case where the answer is determined by who you are rather than which platform is objectively better.

Choose Hims Canada if you are a man who wants a GLP-1 weight management program with male-calibrated clinical intake and the option to address hair loss, erectile dysfunction, or skincare concerns through the same platform. The integrated lifestyle bundle for men is Hims's distinctive value-add, and the GLP-1 clinical intake reflects male metabolic health patterns.

Choose Hers Canada if you are a woman who wants a GLP-1 program with a women-specific clinical framework - particularly if PCOS, hormonal contraception, or women's hair and skin health are relevant to your situation. Hers's intake is built around the factors that most commonly affect GLP-1 candidacy and treatment in female patients, and the adjacent health categories address concerns that frequently co-occur with weight management in women.

If you live in Quebec or New Brunswick, neither brand currently serves you. If you have medical complexity or want real-time physician access, Maple or a platform with on-demand clinical access will serve you better than either sibling brand. If you are a healthy, uncomplicated candidate for GLP-1 treatment and you value gender-specific program framing combined with dispensing convenience, both brands deliver that - choose the one built for you.

External links above are provided for informational purposes. WeightLossInjections.ca does not hold an affiliate relationship with Hims Canada or Hers Canada for the links on this page. GLP-1 medications require a valid prescription from a licensed Canadian physician.